{"entity":{"type":"insider","cik":"0002028254","url":"/insider/0002028254","json_url":"/insider/0002028254.json","name":"Casdin Amplify Fund, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":8,"first":"2024-08-06","last":"2025-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Casdin Amplify Fund, LP","source":"filing","n_filings":8,"first_seen":"2024-08-06","last_seen":"2025-03-04"}],"transactions":[{"id":4657646,"accession":"0000919574-25-001777","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-25-001777","line_url":"/filing/0000919574-25-001777#line-4","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4820959.0,"shares_display":"4,820,959","price_per_share":1.065,"price_display":"1.06","price_state":"stated","total_value":5134321.335,"total_display":"5,134,321.34","total_whole":"5,134,321","shares_owned_after":58846780.0,"shares_owned_after_display":"58,846,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-04","scope":"insider"},{"id":2976271,"accession":"0000919574-24-005134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-005134","line_url":"/filing/0000919574-24-005134#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":2.187,"price_display":"2.19","price_state":"stated","total_value":546750.0,"total_display":"546,750.00","total_whole":"546,750","shares_owned_after":54025821.0,"shares_owned_after_display":"54,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-29","scope":"insider"},{"id":2300369,"accession":"0000919574-24-004878","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":2.1497,"price_display":"2.15","price_state":"stated","total_value":322455.0,"total_display":"322,455.00","total_whole":"322,455","shares_owned_after":53775821.0,"shares_owned_after_display":"53,775,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-26","scope":"insider"},{"id":2300365,"accession":"0000919574-24-004878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":292100.0,"shares_display":"292,100","price_per_share":2.1259,"price_display":"2.13","price_state":"stated","total_value":620975.39,"total_display":"620,975.39","total_whole":"620,975","shares_owned_after":53625821.0,"shares_owned_after_display":"53,625,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-26","scope":"insider"},{"id":2300361,"accession":"0000919574-24-004878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":307900.0,"shares_display":"307,900","price_per_share":1.9578,"price_display":"1.96","price_state":"stated","total_value":602806.62,"total_display":"602,806.62","total_whole":"602,807","shares_owned_after":53333721.0,"shares_owned_after_display":"53,333,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-26","scope":"insider"},{"id":2138859,"accession":"0000919574-24-004812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.9039,"price_display":"1.90","price_state":"stated","total_value":951950.0,"total_display":"951,950.00","total_whole":"951,950","shares_owned_after":53025821.0,"shares_owned_after_display":"53,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-21","scope":"insider"},{"id":2138856,"accession":"0000919574-24-004812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.8734,"price_display":"1.87","price_state":"stated","total_value":936700.0,"total_display":"936,700.00","total_whole":"936,700","shares_owned_after":52525821.0,"shares_owned_after_display":"52,525,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-21","scope":"insider"},{"id":2138853,"accession":"0000919574-24-004812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.8529,"price_display":"1.85","price_state":"stated","total_value":463225.0,"total_display":"463,225.00","total_whole":"463,225","shares_owned_after":52025821.0,"shares_owned_after_display":"52,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-21","scope":"insider"},{"id":2233686,"accession":"0000919574-24-004802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004802","line_url":"/filing/0000919574-24-004802#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200000.0,"shares_display":"1,200,000","price_per_share":1.5946,"price_display":"1.59","price_state":"stated","total_value":1913520.0,"total_display":"1,913,520.00","total_whole":"1,913,520","shares_owned_after":51775821.0,"shares_owned_after_display":"51,775,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-16","scope":"insider"},{"id":3246153,"accession":"0000919574-24-004593","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":1.6192,"price_display":"1.62","price_state":"stated","total_value":890560.0,"total_display":"890,560.00","total_whole":"890,560","shares_owned_after":50575821.0,"shares_owned_after_display":"50,575,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-13","scope":"insider"},{"id":3246149,"accession":"0000919574-24-004593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.6412,"price_display":"1.64","price_state":"stated","total_value":820600.0,"total_display":"820,600.00","total_whole":"820,600","shares_owned_after":50025821.0,"shares_owned_after_display":"50,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-13","scope":"insider"},{"id":3246145,"accession":"0000919574-24-004593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":525408.0,"shares_display":"525,408","price_per_share":1.6149,"price_display":"1.61","price_state":"stated","total_value":848481.3792,"total_display":"848,481.38","total_whole":"848,481","shares_owned_after":49525821.0,"shares_owned_after_display":"49,525,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-13","scope":"insider"},{"id":3246141,"accession":"0000919574-24-004339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004339","line_url":"/filing/0000919574-24-004339#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":569562.0,"shares_display":"569,562","price_per_share":1.6374,"price_display":"1.64","price_state":"stated","total_value":932600.8188,"total_display":"932,600.82","total_whole":"932,601","shares_owned_after":49000413.0,"shares_owned_after_display":"49,000,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-08","filed_date":"2024-08-09","scope":"insider"},{"id":3246135,"accession":"0000919574-24-004339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004339","line_url":"/filing/0000919574-24-004339#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.5724,"price_display":"1.57","price_state":"stated","total_value":786200.0,"total_display":"786,200.00","total_whole":"786,200","shares_owned_after":48430821.0,"shares_owned_after_display":"48,430,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-07","filed_date":"2024-08-09","scope":"insider"},{"id":2846973,"accession":"0000919574-24-004280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004280","line_url":"/filing/0000919574-24-004280#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Eli; Casdin Capital, LLC","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.5839,"price_display":"1.58","price_state":"stated","total_value":316780.0,"total_display":"316,780.00","total_whole":"316,780","shares_owned_after":47930821.0,"shares_owned_after_display":"47,930,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-06","scope":"insider"},{"id":2846970,"accession":"0000919574-24-004280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004280","line_url":"/filing/0000919574-24-004280#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Eli; Casdin Capital, LLC","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":1.6319,"price_display":"1.63","price_state":"stated","total_value":1631900.0,"total_display":"1,631,900.00","total_whole":"1,631,900","shares_owned_after":47730821.0,"shares_owned_after_display":"47,730,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-02","filed_date":"2024-08-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001162194","name":"STANDARD BIOTOOLS INC.","url":"/issuer/0001162194","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2024-08-06","last_seen":"2025-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002028254","retrieved_at":"2026-08-26T19:24:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}